समाचार पर वापस जाएँ
नवीनताAI Understanding ब्रीफिंग

इंसिलिको मेडिसिन के एलेक्स झावोरोंकोव का मानना है कि चीन और एआई दवा उद्योग को अगली सफलता दिला सकते हैं

इनसिलिको मेडिसिन के एलेक्स झावोरोंकोव का मानना है कि चीन और एआई दवा उद्योग को अगली सफलता दिला सकते हैं।

4 min readRead the original reporting
Source-provided image accompanying Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry's next breakthrough
जिम्मेदार रिपोर्टिंगस्रोत रिकार्ड किया गया
प्रकाशक
fortune.com
स्रोत लिंक
fortune.comhttps://fortune.com/2026/09/18/insilico-medicine-bets-china-and-ai-can-deliver-the-drug-industry-next-breakthrough/
स्रोत प्रकार
किसी समाचार आउटलेट द्वारा रिपोर्टिंग - प्रथम-पक्ष दस्तावेज़ नहीं।

जिसकी पुष्टि हम स्वतंत्र रूप से नहीं कर सके: यह दावा नामित आउटलेट के लिए जिम्मेदार है। हमने इसे प्रथम-पक्ष दस्तावेज़ के विरुद्ध सत्यापित नहीं किया। (fortune.com)

प्रसंगइसे 60 सेकंड में समझें

यहां से प्रारंभ करें

स्वयं की जांच करोएआई क्या है? प्रश्नोत्तरी

क्या हुआ?

Insilico Medicine's Alex Zhavoronkov believes China and AI can deliver the drug industry's next breakthrough. The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis. Insilico used AI to identify the disease target and develop the molecule to treat it. The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

इनसिलिको मेडिसिन के एलेक्स झावोरोंकोव का मानना है कि चीन और एआई दवा उद्योग को अगली सफलता दिला सकते हैं।

The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis.

Insilico used AI to identify the disease target and develop the molecule to treat it.

The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

स्रोत विवरण: fortune.com ↗

यह क्यों मायने रखता है?

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry. The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology. Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry.

The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

The company's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

Insilico's success could lead to a shift in the way drugs are developed and marketed.

Interactive Mechanism

इंटरैक्टिव तंत्र: यह वास्तव में कैसे काम करता है

इस विकास के पीछे अंतर्निहित प्रौद्योगिकी का अंतःक्रियात्मक रूप से अन्वेषण करें।

Thinking Budget (Test-Time Tokens):1,024 tokens
Complex Accuracy79%Math & Code Logic
Latency3.2sTime to first full output
Inference Cost$0.0092Per query estimated
Reasoning StyleStep VerificationInternal chain depth
Active Thinking Trace:
1Deconstruct user problem into formal constraints
2Propose candidate hypotheses & step-by-step calculation
3Self-correction: Backtrack and refute subtle edge cases
4Exhaustive consistency check & final output synthesis
Core takeaway: Test-time compute fundamentally changes AI economics. Instead of only scaling during pre-training, giving reasoning models more tokens at inference time allows them to systematically solve PhD-level STEM problems.
इंटरएक्टिव कॉन्सेप्ट चेक+10 Points
What is AI? Quiz

A route planner searches possible journeys using explicit rules. What does this illustrate about AI?

आगे क्या देखना है

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry. The company's success could lead to a shift in the way drugs are developed and marketed, and its use of AI could help improve the understanding of aging biology.

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry.

The company's success could lead to a shift in the way drugs are developed and marketed.

Insilico's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

The company's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

Insilico's success could help address the issue of longevity inequality.

संबंधित मार्गदर्शिकाएँ एवं प्रश्नोत्तरी

एआई क्या है?एआई नैतिकताएआई एजेंटएआई मॉडल की व्याख्याएआई का भविष्यआप जो जानते हैं उसका परीक्षण करें - निःशुल्क AI प्रश्नोत्तरी आज़माएँहमारी शब्दावली में एआई शब्द देखेंएआई मॉडल रिलीज ट्रैकर का पालन करें
क्या यह उपयोगी पाया गया?